目的 建立适用于对熊胆粉进行质量评价与控制的主要胆汁酸类成分的HPLC-ELSD测定方法。方法 使用Agilent SB-C18色谱柱(4.6 mm×250 mm, 5 μm);柱温为40 ℃,10 mmol·L-1乙酸铵水溶液和乙腈作为流动相,梯度洗脱,流速1.0 mL·min-1;ELSD漂移管温度为110 ℃,ELSD氮气流速为2.8 L·h-1,增益为1。结果 牛磺熊去氧胆酸、牛磺鹅去氧胆酸的进样量对数值与峰面积对数值分别在0.087 2~0.348 8和0.076 0~0.342 0 mg·mL-1内呈良好的线性关系;平均回收率分别为101.9%和102.2%,RSD值分别为1.9%和1.5%。结论 所建立的方法简便、快捷、准确,对结果分析显示该法适用于熊胆粉的质量评价与控制。
Abstract
OBJECTIVE To establish an HPLC-ELSD method for simultaneous quantification of the major bile acids in bear bile powder in its quality assessment and control. METHODS The chromatographic separation was carried out on Agilent SB-C18 column (4.6 mm×250 mm, 5 μm) at 40 ℃ using 10 mmol·L-1 ammonium acetate solution and acetonitrile as the mobile phase at a flow rate of 1.0 mL·min-1. The detection was performed using evaporative light scattering detector at drift tube temperature of 110 ℃ and nitrogen flow rate of 2.8 L·h-1 with 1 as the gain. RESULTS The standard curves of tauroursodeoxycholic acid and taurochenodeoxycholic acid showed good relationship in the ranges of 0.087 2-0.348 8 and 0.076 0-0.342 0 mg·mL-1, respectively. The average recoveries were 101.9% (RSD was 1.9%) and 102.2% (RSD was 1.5%), respectively. CONCLUSION The method is simple, rapid, and accurate. The analysis of the result showed that the method could be used i the quality assessment and control of bear bile powder.
关键词
熊胆粉 /
高效液相色谱法 /
蒸发光散射检测器 /
胆汁酸 /
质量评价 /
质量控制
{{custom_keyword}} /
Key words
bear bile powder /
HPLC /
ELSD /
bile acid /
quality assessment /
quality control
{{custom_keyword}} /
中图分类号:
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Ch. P (2010) Vol Ⅰ(中国药典2010年版.一部) [S]. 2010:appendix 27.
[2] Drug Specifications Promulgated by Ministry of Public Health. The Specifications of New Drugs Becoming Official (卫生部药品标准 新药转正标准) [S]. WS3-09(B-09)-96(Z).
[3] XU G J, XU L S, WANG Z T, et al. Varieties Systematics and Quality Research for Commonly Used Traditional Chinese Medicine Southern The Southern Cooperative Vol Ⅲ(常用中药材品种整理和质量研究 南方协作组 第三册) [M]. Fuzhou:Fujian Scientific and Technological Press,1999:860.
[4] XU Y C, WANG Y. The research progress of bear bile powder [J]. West China Pharm Sci (华西药学杂志), 2000, 1(3):200-202.
[5] WU G L, WU X H, DONG T W, et al. The research progress of constitutes without bile acids in bear bile (powder) [J]. Acta Chin Med Pharm (中医药学报) , 2011, 39(3):90-92.
[6] LIU G Y, LI J, WANG X L, et al. The conjugated bile acids of man-made drainage bear bile [J]. Northwest Pharm J (西北药学杂志), 2011, 26(5):322-323.
[7] ZHANG Q M, YUAN H N. The research review of bile acids in bear bile powder [J]. China J Chin Mater Med (中国中药杂志), 1994, 19(3):182-184.
[8] XIE P S, LIANG G H, YAN Y Z. The test and quality inspect of bear bile-TLC comparative authentication of bile acids in commodity of bear bile [J]. Chin Pharm Anal (药物分析杂志), 1981, 1(3):137-144.
[9] ZHANG Q M, JIANG J N, YAN K D, et al. Determination of ursodeoxycholic acid and chenodeoxycholic acid in drainage bear bile [J]. Chin Pharm Anal (药物分析杂志), 1990, 10(2):102-105.
[10] SHI Y, ZOU Q W, WEI F, et al. The research progress of bear gall powder [J]. Chin Pharm Aff (中国药事), 2014, 28(1):82-85.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家十二五“重大新药创制”专项课题——中药质量安全检测和风险控制技术平台(2014ZX09304307-002)
{{custom_fund}}